Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions

Chinese Medical Journal

Volumn 120, Issue 7, 2007, Pages 545-551

  Ge, Lei ^a   Cosgrave, John ^b   Iakovou, Ioannis ^b   Qian, Ju Ying ^a   Agostoni, Pierfrancesco ^b   Sangiorgi, Giuseppe M ^b   Airoldi, Flavio ^b   Michev, Iassen ^b   Chieffo, Alaide ^b   Corvaja, Nicola ^b   Colombo, Antonio ^b   Ge, Jun Bo ^a  

^a FUDAN UNIVERSITY   (China)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

Restenosis; Revascularization; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; PACLITAXEL; PYRIDINE DERIVATIVE; RAPAMYCIN; THIENOPYRIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 34247356122     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200704010-00004     Document Type: Article

References (28)

1. Park SJ, Hong MK, Lee CW, Kim JJ, Song JK, Kang DH, et al. Elective stenting of unprotected left main coronary artery stenosis: effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 2001; 38: 1054-1060.
2. Kelley MP, Klugherz BD, Hashemi SM, Meneveau NF, Johnston JM, Matthai WH Jr, et al. One-year clinical outcomes of protected and unprotected left main coronary artery stenting. Eur Heart J 2003; 24: 1554-1559.
3. Brueren BF, Ernst JM, Suttorp MJ, ten Berg JM, Rensing BJ, Mast EG, et al. Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis: is it time to change the guidelines? Heart 2003; 89: 1336-1339.
4. Hu FB, Tamai H, Kosuga K, Kyo E, Hata T, Okada M, et al. Intravascular ultrasound-guided directional coronary atherectomy for unprotected left main coronary stenoses with distal bifurcation involvement. Am J Cardiol 2003; 92: 936-940.
5. Takagi T, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos V, et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation 2002; 106: 698-702.
6. Park SJ, Lee CW, Kim YH, Lee JH, Hong MK, Kim JJ, et al. Technical feasibility, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing. Am J Cardiol 2002; 90: 374-378.
7. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, Spanos V, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004; 109: 1244-1249.
8. Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol 2001; 37: 832-838.
9. Silvestri M, Barragan P, Sainsous J, Bayet G, Simeoni JB, Roquebert PO, et al. Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol 2000; 35: 1543-1550.
10. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
11. Colombo A, Stankovic G, Orlic D, Corvaja N, Liistro F, Airoldi F, et al. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Catheter Cardiovasc Interv 2003; 60: 145-151.
12. Colombo A, Gaglione A, Nakamura S, Finci L. "Kissing" stents for bifurcational coronary lesion. Cathet Cardiovasc Diagn 1993; 30: 327-330.
13. Schampaert E, Fort S, Adelman AG, Schwartz L. The V-stent: a novel technique for coronary bifurcation stenting. Cathet Cardiovasc Diagn 1996; 39: 320-326.
14. Sheiban I, Albiero R, Marsico F, Dharmadhikari A, Tzifos V, Pagnotta P, et al. Immediate and long-term results of "T" stenting for bifurcation coronary lesions. Am J Cardiol 2000; 85: 1141-1144.
15. Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the "culotte" technique. Am J Cardiol 1998; 82: 943-949.
16. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
17. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000; 49: 274-283.
18. Arampatzis CA, Lemos PA, Hoye A, Saia F, Tanabe K, van der Giessen WJ, et al. Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome. Catheter Cardiovasc Interv 2004; 62: 292-296; discussion 297.
19. Park S, Kim Y, Lee B, Lee S, Lee C, Hong M, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosisPulmonary artery stenting for recurrent lung cancer after left pneumonectomy. J Am Coll Cardiol 2005; 45: 351-356.
20. de Lezo JS, Medina A, Pan M, Delgado A, Segura J, Pavlovic D, et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease. Am Heart J 2004; 148: 481-485.
21. Ajani AE, Waksman R, Cha DH, Gmberg L, Satler LF, Pichard AD, et al. The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation. J Am Coll Cardiol 2002; 39: 1290-1296.
22. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM, et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol 2005; 46: 613-620.
23. Hoye A, Iakovou I, Ge L, van Mieghem CA, Ong AT, Cosgrave J, et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol 2006; 47: 1949-1958.
24. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364: 583-591.
25. Kim YH, Park SW, Hong MK, Park DW, Park KM, Lee BK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006; 97: 1597-1601.
26. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, et al. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation 2004; 109: 2727-2731.
27. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, et al. Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol 2005; 45: 198-203.
28. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, et al. Early and mid-term, results of drug-eluting stent implantation in unprotected left main. Circulation 2005; 111: 791-795.